Morgan Stanley’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $23.2M | Buy |
|
|||||
|
2021
Q2 | $10.7M | Buy |
|
|||||
|
2021
Q1 | $3.31M | Buy |
|
|||||
|
2020
Q4 | $3.08M | Buy |
|
|||||
|
2020
Q3 | $2.09M | Sell |
|
|||||
|
2020
Q2 | $2.22M | Sell |
|
|||||
|
2020
Q1 | $2.44M | Sell |
|
|||||
|
2019
Q4 | $4.32M | Buy |
|
|||||
|
2019
Q3 | $1.55M | Buy |
|
|||||
|
2019
Q2 | $890K | Sell |
|
|||||
|
2019
Q1 | $1.47M | Sell |
|
|||||
|
2018
Q4 | $3.53M | Sell |
|
|||||
|
2018
Q3 | $6.49M | Sell |
|
|||||
|
2018
Q2 | $13.7M | Buy |
|
|||||
|
2018
Q1 | $4.78M | Buy |
|
|||||
|
2017
Q4 | $4.53M | Buy |
|
|||||
|
2017
Q3 | $2.92M | Buy |
|
|||||
|
2017
Q2 | $1.99M | Sell |
|
|||||
|
2017
Q1 | $1.79M | Sell |
|
|||||
|
2016
Q4 | $3.7M | Sell |
|
|||||
|
2016
Q3 | $29.4M | Buy |
|
|||||
|
2016
Q2 | $1.68M | Sell |
|
|||||
|
2016
Q1 | $2.27M | Buy |
|
|||||
|
2015
Q4 | $644K | Sell |
|
|||||
|
2015
Q3 | $399K | Sell |
|
|||||
|
2015
Q2 | $621K | Sell |
|
|||||
|
2015
Q1 | $763K | Sell |
|
|||||
|
2014
Q4 | $819K | Sell |
|
|||||
|
2014
Q3 | $640K | Sell |
|
|||||
|
2014
Q2 | $775K | Sell |
|
|||||
|
2014
Q1 | $793K | Sell |
|
|||||
|
2013
Q4 | $1.57M | Buy |
|